Home > Products > Finished Pharmaceutical Products > Antibiotic & Antimicrobial > Amoxicillin Tablet BP 500MG

Amoxicillin Tablet BP 500MG

Payment Type:
T/T,L/C
Incoterm:
FOB
Min. Order:
100000 Tablets
Transportation:
Ocean,Land,Air
Share:
  • Product Description
Overview
Product Attributes

Model No.500mg

Supply Ability & Additional Information

TransportationOcean,Land,Air

Payment TypeT/T,L/C

IncotermFOB

INDICATION:

Infections of the Ear, Nose, and Throat

Amoxicillin Tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae.

Infections of the Genitourinary Tract

Amoxicillin Tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis, or Enterococcus faecalis.

Infections of the Skin and Skin Structure

Amoxicillin Tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), Staphylococcus spp., or E. coli.

Infections of the Lower Respiratory Tract

Amoxicillin Tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), S. pneumoniae, Staphylococcus spp., or H. influenzae.

Helicobacter pylori Infection

Triple therapy for Helicobacter pylori with clarithromycin and lansoprazole:

Amoxicillin Tablets, in combination with clarithromycin plus lansoprazole as triple therapy, are indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1 year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Dual therapy for H. pylori with lansoprazole:

Amoxicillin Tablets , in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1 year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.


500 MG

100`s/box,100boxes/carton

1 G

200`s/box,50boxes/carton


If you are a distributor, please inquire with us about product registration, importing and/or marketing our products in your country or region.

If you are a consumer, don't hesitate to contact us about more information for this product.

Product Categories : Finished Pharmaceutical Products > Antibiotic & Antimicrobial

Email to this supplier
  • *Subject:
  • *To:
    Mr. Andy
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
Send Inquiry
*
*

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send